CN100592916C - 治疗肾结石病的中药组合物及其生产方法 - Google Patents
治疗肾结石病的中药组合物及其生产方法 Download PDFInfo
- Publication number
- CN100592916C CN100592916C CN200510049219A CN200510049219A CN100592916C CN 100592916 C CN100592916 C CN 100592916C CN 200510049219 A CN200510049219 A CN 200510049219A CN 200510049219 A CN200510049219 A CN 200510049219A CN 100592916 C CN100592916 C CN 100592916C
- Authority
- CN
- China
- Prior art keywords
- ethanol
- chinese medicine
- medicine composition
- decocted
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 46
- 208000015924 Lithiasis Diseases 0.000 title claims abstract description 12
- 239000000203 mixture Substances 0.000 title claims description 24
- 238000002360 preparation method Methods 0.000 title description 3
- 241000218176 Corydalis Species 0.000 claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 39
- 239000008187 granular material Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 241000237636 Pheretima Species 0.000 claims description 10
- 241000222640 Polyporus Species 0.000 claims description 10
- 210000003038 endothelium Anatomy 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 8
- 238000005325 percolation Methods 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 238000005516 engineering process Methods 0.000 claims description 5
- 241000241550 Cyathula Species 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 4
- 235000019425 dextrin Nutrition 0.000 claims description 4
- 238000012856 packing Methods 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 238000001694 spray drying Methods 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 2
- 230000002485 urinary effect Effects 0.000 abstract description 6
- 206010029148 Nephrolithiasis Diseases 0.000 abstract description 5
- 238000002156 mixing Methods 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 2
- 239000002245 particle Substances 0.000 abstract description 2
- 235000008499 Canella winterana Nutrition 0.000 abstract 1
- 244000080208 Canella winterana Species 0.000 abstract 1
- 241000737263 Lygodium Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 229940017545 cinnamon bark Drugs 0.000 abstract 1
- 238000000151 deposition Methods 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 15
- 230000000694 effects Effects 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 11
- 230000036407 pain Effects 0.000 description 11
- 238000012360 testing method Methods 0.000 description 10
- 238000002560 therapeutic procedure Methods 0.000 description 8
- 210000002700 urine Anatomy 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 230000027939 micturition Effects 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000000913 Kidney Calculi Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 3
- 238000003759 clinical diagnosis Methods 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000000626 ureter Anatomy 0.000 description 3
- 208000031868 Calculus ureteric Diseases 0.000 description 2
- 206010009866 Cold sweat Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- YIKSCQDJHCMVMK-UHFFFAOYSA-N Oxamide Chemical compound NC(=O)C(N)=O YIKSCQDJHCMVMK-UHFFFAOYSA-N 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 208000029523 Interstitial Lung disease Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 206010066901 Treatment failure Diseases 0.000 description 1
- 208000000014 Ureteral Calculi Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- XEEVLJKYYUVTRC-UHFFFAOYSA-N oxomalonic acid Chemical compound OC(=O)C(=O)C(O)=O XEEVLJKYYUVTRC-UHFFFAOYSA-N 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000003405 preventing effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 210000001625 seminal vesicle Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 201000011086 ureterolithiasis Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 201000010653 vesiculitis Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200510049219A CN100592916C (zh) | 2005-01-26 | 2005-01-26 | 治疗肾结石病的中药组合物及其生产方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200510049219A CN100592916C (zh) | 2005-01-26 | 2005-01-26 | 治疗肾结石病的中药组合物及其生产方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1679857A CN1679857A (zh) | 2005-10-12 |
CN100592916C true CN100592916C (zh) | 2010-03-03 |
Family
ID=35066863
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200510049219A Expired - Fee Related CN100592916C (zh) | 2005-01-26 | 2005-01-26 | 治疗肾结石病的中药组合物及其生产方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100592916C (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102872437B (zh) * | 2012-09-27 | 2014-09-17 | 强红兵 | 一种治疗肾结石的专病消石汤 |
CN104306737A (zh) * | 2014-11-09 | 2015-01-28 | 朱海燕 | 一种用于治疗肾结石的中药组合物及其制备方法和应用 |
CN105943664A (zh) * | 2016-06-27 | 2016-09-21 | 杨大妹 | 一种治疗石淋的中药 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1056775C (zh) * | 1997-01-13 | 2000-09-27 | 李国华 | 一种治疗泌尿系结石的药物 |
-
2005
- 2005-01-26 CN CN200510049219A patent/CN100592916C/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1056775C (zh) * | 1997-01-13 | 2000-09-27 | 李国华 | 一种治疗泌尿系结石的药物 |
Non-Patent Citations (2)
Title |
---|
治疗泌尿系结石病概述. 刘兴武.湖北中医杂志,第16卷第2期. 1994 |
治疗泌尿系结石病概述. 刘兴武.湖北中医杂志,第16卷第2期. 1994 * |
Also Published As
Publication number | Publication date |
---|---|
CN1679857A (zh) | 2005-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101732660B (zh) | 一种治疗前列腺疾病的中药制剂及其制备方法 | |
CN101095825A (zh) | 一种治疗乳腺增生、乳腺炎的中成药及其制备方法 | |
CN1742903B (zh) | 治疗前列腺炎、前列腺增生的药物及其制备方法 | |
CN102120020A (zh) | 一种治疗乳腺增生病和子宫肌瘤的药物组合物及其制备方法 | |
CN100592916C (zh) | 治疗肾结石病的中药组合物及其生产方法 | |
CN100372559C (zh) | 一种治疗骨折的中药复方制剂 | |
CN104623196A (zh) | 一种用于治疗慢性肾炎的中药组合物及其制备方法和应用 | |
CN103142902B (zh) | 治疗乳腺增生疾病的中药组合物和制剂及其制备方法 | |
CN100548363C (zh) | 治疗良性前列腺增生症的药物及其制备方法 | |
CN100464770C (zh) | 一种治疗慢性前列腺炎的药物及其制备方法 | |
CN105434915A (zh) | 一种用于治疗犬猫泌尿道结石的药物组合物及其制备方法 | |
CN102038799B (zh) | 乳癖消制剂在制备治疗痛经的药物中的用途 | |
CN101317881A (zh) | 中药肾茶排石复方及制剂 | |
CN100434112C (zh) | 治疗乳腺增生性疾病的纯中药药物及制备方法 | |
CN101028349B (zh) | 治疗前列腺炎、前列腺增生的外用药物及制备方法 | |
CN101152532B (zh) | 一种治疗经前期紧张综合征的中药制剂 | |
CN1712055A (zh) | 一种治疗泌尿系结石的中药制剂(溶石胶囊) | |
CN101011484B (zh) | 一种治疗泌尿系统感染的药物及其胶囊的制备方法 | |
CN100460001C (zh) | 一种治疗慢性前列腺炎的中药组合物及其制备方法 | |
CN103386101B (zh) | 一种治疗非特异性膀胱炎的中药制剂及其制备方法 | |
CN109602838A (zh) | 一种治疗慢性炎症的中药组合物及其制备方法和应用 | |
CN1183952C (zh) | 一种治疗子宫肌瘤病药物及其制备方法 | |
CN103520638B (zh) | 一种治疗前列腺肥大症的中药复方组合物及其制备方法及其应用 | |
CN103157048A (zh) | 一种治疗慢性盆腔炎的中药组合物及其制备方法 | |
CN103055192B (zh) | 一种妇炎康复咀嚼片 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: ZHEJIANG HANGZHOU XINFU PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: XINFU PHARMACEUTICAL IND CO., LTD., HANGZHOU Effective date: 20070907 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20070907 Address after: 311300 Jin Town, Hangzhou City, Zhejiang, Ling'an Applicant after: ZHEJIANG HANGZHOU XINFU PHARMACEUTICAL Co.,Ltd. Address before: 311305 Ling'an Economic Development Zone, Zhejiang, Hangzhou Applicant before: ZHEJIANG HANGZHOU XINFU PHARMACEUTICAL Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 311300 Jin Town, Hangzhou City, Zhejiang, Ling'an Patentee after: YIFAN XINFU PHARMACEUTICAL Co.,Ltd. Address before: 311300 Jin Town, Hangzhou City, Zhejiang, Ling'an Patentee before: ZHEJIANG HANGZHOU XINFU PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20160623 Address after: 311300 Zhejiang province Hangzhou city Ling'an City Jin Nan Street Shang Gua 9 Patentee after: HANGZHOU XINFU SCIENCE & TECHNOLOGY Co.,Ltd. Address before: 311300 Jin Town, Hangzhou City, Zhejiang, Ling'an Patentee before: YIFAN XINFU PHARMACEUTICAL Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100303 Termination date: 20210126 |